Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending March 18, 2022

Drug Industry TRx: -1.4% w/w

Vascepa
TRx 71,000; -6.0% (-4,553) w/w; -15.3% y/y
NRx 33,222; -7.5% (-2,690) w/w; -16.1% y/y
Ref 37,778; -4.7% (-1,863) w/w; -14.6% y/y

Lovaza (Generic & Brand)
TRx 63,479; -3.1% (-2,062) w/w; +0.8% y/y
NRx 33,234; -3.1% (-1,048) w/w; +3.4% y/y
Ref 30,245; -3.2% (-1,015) w/w; -1.8% y/y

Generic Vascepa
TRx 30,609; +0.6% (+185) w/w; As % of total V: 30.1%
NRx 17,566; -1.6% (-294) w/w; As % of total V: 34.6%
Ref 13,043; +3.8% (+479) w/w; As % of total V: 25.7%

Generic Vascepa by Manufacturer
Hikma - TRx 7,685 (-699); Generic share 25.1%; Total V share 7.6%
Reddy - TRx 14,319 (-13); Generic share 46.8%; Total V share 14.1%
Apotex - TRx 8,606 (+898); Generic share 28.1%; Total V share 8.5%

Vascepa + Generic Vascepa
TRx 101,609; -4.1% (-4,368) w/w; +8.8% y/y
NRx 50,788; -5.5% (-2,983) w/w; +12.5% y/y
Ref 50,821; -2.7% (-1,384) w/w; +5.3% y/y